Printer Friendly

"CLUPS": A New Culture Medium for the Axenic Growth of Entamoeba histolytica.

1. Introduction

Amebiasis is one of the main causes of infectious disease in Mexico and African countries. The World Health Organization reported in 1997 that there were about 40 million disease cases worldwide per year and estimated that over 400 million people were asymptomatically infected [1, 2]. Unfortunately, there are no more recent world reports.

On the other hand, since the start of this century, novel nonpathogenic Entamoeba species have been recognized [3, 4]. Ongoing improvement of molecular diagnostic tools facilitates a better differentiation and identification of species [5]. The incorporation of new diagnostic techniques confirms that the protozoan pathogen Entamoeba histolytica remains a major cause of gastrointestinal disease in Mexico and other parts of the world [6, 7]. PCR-based studies reveal that E. histolytica is present in 16-20% of people with a gastrointestinal disorder [6, 7]. Better culture media could facilitate the in vitro study of microorganisms such as E. histolytica. Ideally, cultured parasites should present the same growth and virulence characteristics as their counterparts in their natural habitat [8]. Axenic cultivation of E. histolytica was first accomplished by Diamond in 1961 [9], using a diphasic medium composed of a serum-enriched agar base covered by a broth supplemented with chicken extract and vitamins. In 1968, Diamond described a new monophasic medium called TPS-1 [10] that received great acceptance among researchers who cultivated amebas. In 1978, a new medium was introduced that contained a yeast extract instead of Panmede (a papain digest of ox liver) [11]. This new medium, TYI-S-33, became the most popular [11]. A casein-free alternative, YI-S, has never been widely used [12, 13]. In 1988, our group reported an in-house developed axenic culture medium, PEHPS [14]. PHEPS is based on TPS-1 but replaces Panmede with the pancreatic digest of raw beef liver as described in [14]. The main components of the E. histolytica axenic culture media are a source of peptides, amino acids (trypticase or casein digest peptone), nucleic acids (yeast extract), carbohydrates (glucose), lipids (serum), and vitamins. The development of a new culture medium for intestinal protozoan allows learning about the biology of parasites, their growth rate, virulence factors (like phospholipase activity), susceptibility to new drugs, and the appearance of resistant strains, among other aspects [15].

The PEHPS medium was designed because of the need of an economic medium without the interlot variability present in manufactured culture media. In the commercial media TYI-S-33 and TPS, the supplements, Panmede, and yeast extract present batch-to-batch variability [16], whereas our in-house PEHPS is produced as a single lot that can take up to a year to be consumed [14]. The main components of PEHPS are casein peptone, liver and pancreas extract, and bovine serum [14]. Bovine serum is essential and cannot be substituted; trophozoites died at day three in serum-free cultures [17]. However, the inconvenience of beef extracts nowadays is that remnants of antibiotics and antiparasitic drugs may be present, as has been proven for the liver of cattle [18, 19]. We previously demonstrated that ivermectin and similar antiparasitic drugs inhibit the in vitro growth of E. histolytica [20].

The main objective of this study was to demonstrate that the new CLUPS medium facilitates proper E. histolytica growth without affecting virulence factors nor the ability to cause hepatic abscesses in animal models.

2. Material and Methods

2.1. Biologic Material. Beef liver, lungs, and pancreas and pork pancreas were obtained at a local slaughterhouse from recently sacrificed animals. All organs were transported in ice and manipulated as previously described [14]. Extracts were frozen at -20[degrees]C until use.

2.2. Medium Preparation. The composition and preparation of CLUPS medium are the same as those of PEHPS medium [14], except for the substitution of beef liver (PEHPS) by beef lung (CLUPS). The main components of CLUPS are casein, lung and pancreas extract, and bovine serum. Table 1 compares the composition of the three media, PEHPS, TYI-S-33, and CLUPS. Once prepared, the basal medium was sterilized by filtration over a 0.22-[micro]m filter (Millipore, Millipore Corporation, Billerica, MA, USA) and stored in 5.5mL aliquots at -20[degrees]C. Just before use, CLUPS is supplemented with 8.3% v/vbovine serum. Bovine serum was also produced in-house as follows: about 15 L fresh blood from cows for human consumption was collected in a sterile way at a local slaughterhouse. After blood coagulation, the serum was recovered, and the complement was heat-inactivated (56[degrees]C, 1 h). Next, the serum was prefiltered through Whatman No. 1 paper before being sterile-filtered through a series of sterile Millipore HAWP filters (Millipore, Millipore Corporation, Billerica, MA, USA) from 5 to 0.22 [micro]m. Serum was frozen at -70[degrees]C until use.

2.3. Culture Strains. Trophozoites from the E. histolytica HM1: IMSS strain were cultured in TYI-S-33 medium under axenic conditions. The reference strain was maintained in 13 x 100 mm borosilicate screw-capped tubes containing 5.5 mL TYI-S-33 medium plus 0.5 mL bovine serum. Each tube was inoculated with 1 x [10.sup.4] trophozoites/mL and incubated at 36.5[degrees]C for 72 h until the amebas were harvested as described [21]. Ameba density was determined with a hemocytometer according to Lopez-Revilla and Rodriguez-Baez [22] before being reseeded.

For assays, the parasites were maintained in axenic conditions at 36.5[degrees]C for 30 days by serial subcultivation in TYI-S-33, PEHPS, or CLUPS medium.

Growth curves of E. histolytica in TYI-S-33, PEHPS, or CLUPS medium were determined in quintuplicate every 24 h for 5 days. A hemocytometer was used to determine the number of trophozoites/mL, and the doubling time was calculated by linear regression [23]. The yields in each culture were determined at the end of the logarithmic growth phase (72 h of incubation).

2.4. Collection Phospholipase-Containing Subcellular Fraction. Phospholipase A activity can be recovered from fraction P30 using a previously described cellular fractionation method [24]. Cultured protozoa was harvested and washed twice with phosphate-buffered saline, pH 7.0 by centrifugation (1500 x g, 10 min). The protozoa was resuspended and diluted in 2 volumes of Hank's balanced salt solution. Next, the trophozoites were homogenized using a motor-driven Elvehjem-Potter Teflon/glass homogenizer (100 strokes) to obtain the "total extract". The "total extract" was centrifuged at 30,000 x g for 10 min. Both the supernatant (S30) and the precipitate (P30) were stored in 200-Il aliquots at -70[degrees]C until use.

2.5. Detection of Phospholipase A Activity. The phospholipase activity of types A1 and A2 was determined according to Vargas-Villarreal et al. [24]. The assay chromatographically analyzes radioactive hydrolysis products, either free fatty acids (FFA) or lysophosphatidylcholine (LPC), of 2-palmitoyl-(2-palmitoyl- [sup.14]C)-phosphatidylcholine ([sup.14]C-PC). Radioactivity in the chromatographic spots corresponding to C-LPC, but not in those of C-FFA, indicates type A1 activity; in the opposite case, there would be type A2 phospholipase activity. Radioactive substrates were purchased from New England Nuclear, Boston, Mass. Each of the above (4 [micro]Ci per assay) was mixed with 1.0 mL 0.1 M sodium Trisbase buffer (pH 8.0), 2 mM CaCl2, 0.2% Triton X-100, and 0.27 mM phosphatidylcholine. The mixtures were sonicated with an Ultratrip Labsonic System (Lab-Line Instrument Inc., Melrose Park, IIinois), which was operated at 40 W for 60 s. The resultant emulsion was distributed in 0.5-mL aliquots and stored at -70[degrees] C until use.

The P30 fraction (10 [micro]L containing 200 [micro]g total proteins) was mixed with 10 [micro]L substrate and incubated at 36.5[degrees]C (water bath) for 2.5 h. The reaction was stopped by adding 25 [micro]L 5% trichloroacetic acid/n-butanol stop solution containing the following internal controls: rat liver free fatty acids (FFA; final concentration 1 mg/mL), egg-yolk lysophosphatidylcholine (LPC; 1 mg/mL), and egg-yolk phosphatidylcholine (PC; 0.75 mg/mL).

The hydrolysis mixtures were located drop-by-drop on the origins of 10 x 10 cm silica-gel thin-layer chromatography plates (60 mesh; Merck, Darmstadt, Germany). The plates were placed into a developing tank with a solvent system composed of chloroform:methanol:acetic acid:water (140:40:16:8 volumes). The lipid spots were developed by exposure to iodine vapor [25]. The spots belonging to PC, LPC, and FFA were identified, recovered by scratching them off, mixed with 5 mL liquid scintillation mixture (6% 2,5- diphenyloxazole/toluene) in 20-mL borosilicate vials, and quantified on a liquid scintillation counter (Packard Tri-Carb 1600TR, Beckman Instruments) [24]. All determinations were performed three times, in triplicate, and presented as mean [+ or -] SD. Specific phospholipase activity (PLAU/mg of total protein/h) was calculated by arbitrarily defining 1 unit of phospholipase (PLAU) as the hydrolysis of 1 pmol of (2-[sup.14]C-PA)-PC.

2.6. Quantifications of Proteins. Protein concentrations were quantified by the Lowry method [26].

2.7. Virulence Test by Liver Abscess Formation. All animal work realized in this research was realized according to international ethical guidelines. All procedures were performed by a veterinarian expert in animal handling. Freshly weaned, male golden hamsters (Mesocricetus auratus), weighing 40-60 g [27], were anesthetized intraperitoneally with 63 mg/kg sodium pentobarbital Anestesal[R] (Smithkline Norden, Mexico) using a syringe with a G25 needle, so that the hamsters would remain anesthetized for one hour including a 15-min deep anesthesia. This way, suffering of the animals, was minimized. Laparotomy was realized in each hamster under aseptic conditions. The ventral lobe of the liver was inoculated with a 0.1 mL suspension of basal medium containing [10.sup.6] trophozoites grown in PEHPS, CLUPS, or TYI-S-33 medium (n=4). The negative control group was inoculated with parasite-free medium. After inoculation, the incision was sutured using a continuous padlock [28]. After surgery, hamsters were kept under standard laboratory conditions with water and food ad libitum for three days, until they were sacrificed by euthanasia with an anesthetic overdose (130 mg/kg sodium pentobarbital). After making sure that the animal had died (No breathing or heartbeat), an exploratory laparotomy was performed to evaluate liver abscess formation by direct observation and measurement of the lesion. Here to, fine cuts were made in the liberated livers of all animals with a sterile scalpel blade until liver lesions were found and could be measured.

2.8. Statistical Analysis. Student's t-test was used to compare groups with a normal distribution; a p-value < 0.05 was considered significant. All statistics were carried out with SPSS v18.

3. Results

After an adaptation lag, trophozoites of E. histolytica HM 1: IMSS, transferred from TYI-S-33 to CLUPS and PEHPS media, grew better in the latter 2 media at 72 and 96 h after transfer, CLUPS > PEHPS > TYI-S-33 (Figure 1). Trophozoites grown in CLUPS medium had 32% and 19% better yield than those grown in TYI-S-33 medium at 72 and 96 h, respectively, whereas the yield in CLUPS was 19% and 8% higher than the one in PEHPS at the same incubation times. CLUPS medium allowed for the shortest doubling time of growing E. histolytica trophozoites (21.8 h); the doubling time in PEHPS was 22.0 h and in TYI-S-33 23.2 h.

The radioactive products (2-[sup.14]C-PA)-LPC and ([sup.14]C) palmitic acid accumulated as a function of incubation time; the increase was almost linear the first 60 min, then slowed down, and reached a plateau at 90 min. Trophozoites grown in any of the three-culture media maintained the production of phospholipases [A.sub.1] and [A.sub.2] (Figure 2). However, the production was higher when parasites were cultured in CLUPS. At 120 min for both phospholipases [A.sub.1] and [A.sub.2], the difference was statistically significant between CLUPS and TYI-S-33, but not between CLUPS and PEHPS (Figure 2). Finally, the accumulation of hydrolysis products from (2-[sup.14]C-PA)-PC increases linearly as a function of P30 protein amount in both [A.sub.1] and [A.sub.2] phospholipase activity (Figure 3).

All hamsters that had been inoculated with trophozoites cultured in any of the tested media showed the formation of liver abscesses. All abscesses had a diameter greater than 3 mm.

4. Discussion

We introduce a new culture medium (CLUPS) for the axenic growth of E. histolytica. CLUPS medium is a modification of the PEHPS medium [14]; the raw beef liver of PEHPS was replaced by raw beef lung in CLUPS. CLUPS was designed to avoid antibiotic remnants in beef liver. Growth curve and virulence factor analysis was expected to be similar to conventional TYI-S-33 medium or the in-house made PEHPS. Unexpectedly, we found that trophozoites grown in the CLUPS medium showed higher phospholipase activity than that the ones grown in TYI-S-33 medium [11].

At 72 h of cultivation, the trophozoite yield in CLUPS was 30% higher than in TYI-S-33. This superior performance was significant and cannot be explained by simple media variability [16]. When comparing the composition of both media, the main difference is the absence of the yeast extract in CLUPS medium. The yeast extract is considered an essential component in the culture media for amebas [29,30]. However, we have maintained the E. histolytica HM-1 strain in continuous culture with yeast-extract-free PEHPS for over 25 years [14, 21]. The above proves that a yeast extract is not essential for trophozoite growth.

When we compared the growth pattern between CLUPS and PEHPS, it seems that trophozoite growth starts and ends earlier in CLUPS than in PEHPS. This retardation in PEHPS may be due to the presence of antiparasitic or antibiotic residues in the raw beef liver [18-20], which rather than growth inhibition may be the cause of a growth delay.

The production of phospholipases is the same for both media; the seemingly higher production in CLUPS was not statistically significant. So far, it seems that the CLUPS medium outperforms PEHPS medium for the culture of E. histolytica trophozoites; however this would have to be demonstrated by prolonged use.

The effectiveness of virulence factors in amebas is demonstrated in vivo by the formation of hepatic abscesses; it has even been shown that amebas increase their virulence after inoculating them in hamster liver and recovering them from lesions [31]. Although it has been mentioned that pathogenic amebas induce liver abscesses whereas nonpathogenic amebas are unable to produce them, recently it has been shown that some nonpathogenic species can produce liver abscesses [32]. We carried out an assay to demonstrate that the trophozoites of the HM1: IMSS strain grown in the CLUPS medium are capable of producing hepatic abscesses as well as those grown in PEHPS and TYI-S-33.

Alternatively, the CLUPS medium may contain factors that favor proper growth and an increased phospholipase activity. To verify if lung extracts have better factors than the other culture media, we will compare the growth and enzymatic activity of amebas cultivated in either CLUPS or PEHPS medium. At the moment no commercial medium has extracts from animal organs [10,11].

The successful culture of this parasite in this new CLUPS medium allows for the execution of assays in an economical and stable environment. Similar to the PEHPS medium, CLUPS avoids assay variability due to interlot variability common in commercial culture media [13]. In this regard, it should be mentioned that a large batch of concentrated organ extract suffices for over a year's supply for in-house prepared medium [14].

The reliable cultivation of E. histolytica in CLUPS medium allows us to investigate the biology of this parasite, to study its virulence factors, to develop better diagnostic methods, and to test new drugs for better treatments.

In conclusion, we consider that the CLUPS medium is a superior alternative culture medium, which is both economic and free of the interlot variability present in commercial T YIS-33. 10.1155/2018/2796516

Ethical Approval

This study was registered in the local research committee of the Social Security Mexican Institute. The international guiding principles for medical research involving animals were followed.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.


This study was supported by FIS/IMSS/PR0T/G15/1403. The authors are grateful to Dr. Gerardo Lozano for excellent veterinary assistance.


[1] World Health Organization, "Amoebiasis-an expert consultation," Weekly Epidemiological Record, vol. 72, pp. 97-99,1997.

[2] WHO/Department of Communicable Disease Prevention, Control and Eradication. Prevention and control of intestinal parasitic infections. WHO Technical Report Series, 749, 25-26, 1987.

[3] W. A. Petri and K. Chadee, "Recent Advances in Amebiasis," Critical Reviews in Clinical Laboratory Sciences, vol. 33, no. 1, pp. 1-37, 2008.

[4] C. Graham Clark and L. S. Diamond, "The Laredo strain and other 'Entamoeba histolytica-like' amoebae are Entamoeba moshkovskii," Molecular and Biochemical Parasitology, vol. 46, no. 1, pp. 11-18, 1991.

[5] I. K. M. Ali, C. G. Clark, and W. A. Petri Jr., "Molecular epidemiology of amebiasis," Infection, Genetics and Evolution, vol. 8, no. 5, pp. 698-707, 2008.

[6] P. Lepez-Lepez, M. C. Martinez-Lepez, X. M. Boldo-Leen et al., "Detection and differentiation of Entamoeba histolytica and Entamoeba dispar in clinical samples through PCR-denaturing gradient gel electrophoresis," Brazilian Journal of Medical and Biological Research, vol. 50, no. 4, Article ID e5997, 2017.

[7] M. A. Al-Areeqi, H. Sady, H. M. Al-Mekhlafi et al., "First molecular epidemiology of Entamoeba histolytica, E. dispar and E. moshkovskii infections in Yemen: different species-specific associated risk factors," Tropical Medicine & International Health, vol. 22, no. 4, pp. 493-504, 2017.

[8] F. L. Schuster, "Cultivation of pathogenic and opportunistic free-living amebas," Clinical Microbiology Reviews, vol. 15, no. 3, pp. 342-354, 2002.

[9] L. S. Diamond, "Axenic Cultivation of Entamoeba histolytica," Science, vol. 134, no. 3475, pp. 336-337, 1961.

[10] L. S. Diamond, "Techniques of Axenic Cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like Amebae," The Journal of Parasitology, vol. 54, no. 5, pp. 1047-1056, 1968.

[11] L. S. Diamond, D. R. Harlow, and C. C. Cunnick, "A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 72, no. 4, pp. 431-432,1978.

[12] L. S. Diamond, C. G. Clark, and C. C. Cunnick, "YI-S, a casein-free medium for axenic cultivation of Entamoeba histolytica, related Entamoeba, Giardia intestinalis and Trichomonas vaginalis," Journal ofEukaryotic Microbiology, vol. 42, no. 3, pp. 277-278, 1995.

[13] C. G. Clark and L. S. Diamond, "Methods for cultivation of luminal parasitic protists of clinical importance," Clinical Microbiology Reviews, vol. 15, no. 3, pp. 329-341, 2002.

[14] S. Said Fernandez, J. Vargas Villarreal, J. Castro Garza et al., "PEHPS medium: An alternative for axenic cultivation of Entamoeba histolytica and E. Invadens," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 82, no. 2, pp. 249-253,1988.

[15] S. G. Bradley, D. M. Toney, Y. Zhang, and F. Marciano-Cabral, "Dependence of growth, metabolic expression, and pathogenicity of Naegleria fowleri on exogenous porphyrins," The Journal of Parasitology, vol. 82, no. 5, pp. 763-768,1996.

[16] J. Castro-Garza, F. Anaya-Velazquez, S. Said-Fernandez, and MT. Gonzalez-Garza, "Comparable growth of a Trichomonas vaginalis strain in PEHPS and TYI-S-33 media," Archives of Medical Research, vol. 27, pp. 567-569,1996.

[17] B. D. Mata-Cardenas and S. Said-Fernandez, "Desarrollo de un medio simplificado para el cultivo ax[R]nico de Entamoeba histolytica," Archivos De Investigacion Medica, vol. 21, pp. 247-251, 1990.

[18] M. S. Ali, T. Sun, G. E. Mcleroy, and E. T. Phillippo, "Confirmation of Eprinomectin, Moxidectin, Abamectin, Doramectin, and Ivermectin in Beef Liver by Liquid Chromatography/Positive Ion Atmospheric Pressure Chemical Ionization Mass Spectrometry," Journal ofAOAC International, vol. 83, no. 1, pp. 39-52, 2000.

[19] W. A. Moats, "High-performance liquid chromatographic determination of penicillin G, penicillin V and cloxacillin in beef and pork tissues," Journal of Chromatography A, vol. 593, no. 1-2, pp. 15-20, 1992.

[20] F. Gonzalez-Salazar, B. D. Mata-Cardenas, and J. Vargas-Villarreal, "Sensibility of Entamoeba histolytica trophozoites to ivermectin," Medicina, vol. 69, no. 3, pp. 318-320, 2009.

[21] S. Said-Femandez and B. D. Mata-Cardenas, "Axenic cultivation of Entamoeba histolytica in suspension," Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 86, no. 2, pp. 173-174, 1992.

[22] Lopez-Revilla R, Rodriguez-Baez J. Manual para el cultivo axenico de Entamoeba histolytica. Ciencia y Desarrollo. Maxico: Consejo Nacional de Ciencia y Tecnologia. 1981.

[23] J. Vargas-Villarreal, B. D. Mata-Cardenas, R. Palacios-Corona et al., "Trichomonas vaginalis: Identification of soluble and membrane-associated phospholipase A1 and A2 activities with direct and indirect hemolytic effects," Journal of Parasitology, vol. 91, no. 1, pp. 5-11, 2005.

[24] J. Vargas-Villarreal, H. Martinez-Rodriguez, J. Castro-Garza, B. D. Mata-Cardenas, M. T. Gonzalez-Garza, and S. Said-Fernaandez, "Identification ofEntamoeba histolytica intracellular phospholipase A and lysophospholipase L1 activities," Parasitology Research, vol. 81, no. 4, pp. 320-323, 1995.

[25] J. P. Skipsky and M. Barclay, "Thin-Layer chromatography of lipids," in Methods in Enzymology, pp. 30-599, Academic Press, USA, 1969.

[26] O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurements with Folin-phenol reagent," The Journal of Biological Chemistry, vol. 193, pp. 265-275, 1951.

[27] Kretschmer R. Amibiasis; Infeccioan y Enfermedad por Entamoeba histolytica. Ed. Trillas. D.F. p.p. 15-36,1994.

[28] M. T. Gonzalez-Garza, J. Castro-Garza, F. Anaya-Velazquez et al., "Anti-amoebic effect of gossypol in golden hamsters with experimental hepatic amoebic abscess," Journal of Pharmaceutical Sciences, vol. 2, no. 3, pp. 153-156,1996.

[29] H. Dagci, I. C. Balcioglu, H. Ertabaklar, O. Kurt, and M. Atambay, "Effectiveness of peptone-yeast extract (P-Y) medium in the cultivation and isolation of Entamoeba histolytica/Entamoeba dispar in Turkish patients," Diagnostic Microbiology and Infectious Disease, vol. 45, no. 2, pp. 127-130, 2003.

[30] S. Kobayashi, E. Imai, A. Haghighi, S. A. Khalifa, H. Tachibana, and T. Takeuchi, "Axenic cultivation of Entamoeba dispar in newly designed yeast extract-iron-gluconic acid-dihyrdoxyacetone-serum medium," Journal of Parasitology, vol. 91, no. 1, pp. 1-4, 2005.

[31] W. B. Lushbaugh, A. B. Kairalla, C. B. Loadholt, and F. E. Pittman, "Effect of hamster liver passage on the virulence of axenically cultivated Entamoeba histolytica," The American Journal of Tropical Medicine and Hygiene, vol. 27, no. 2 I, pp. 248-254, 1978.

[32] S. S. Dolabella, J. Serrano-Luna, F. Navarro-Garcia et al., "Amoebic liver abscess production by entamoeba dispar," Annals of Hepatology, vol. 11, no. 1, pp. 107-117, 2012.

F. Gonzalez-Salazar (iD), (1,2) I. Meester (iD), (2) F. J. Guzman De La Garza (iD), (1) L. H. De La Garza-Salinas (iD), (3) A. Sampayo-Reyes, (4) J. N. Garza-Gonzalez, (2) O. Monsivais-Diaz, (1) B. A. Barba-Davila, (5) M. E. Hemandez-Garcia (iD), (1) and J. Vargas-Villarreal (iD)(1)

(1) Centro de Investigacion Biomedica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico

(2) Departamento de Ciencias Basicas, Vicerrectoroa de Ciencias de la Salud, Universidad de Monterrey, Monterrey, Mexico

(3) Coordinacion de Planeacion y Enlace Institucional, Instituto Mexicano Del Seguro Social, Delegacion Nuevo Leon, Monterrey, Mexico

(4) Departamento de Inmunologoa y Virologoa, Universidad Autonoma de Nuevo Leon, San Nicolas de los Garza, Mexico

(5) Escuela de Ingenieria y Ciencias, Instituto Tecnologico de Estudios Superiores de Monterrey, Monterrey, Mexico

Correspondence should be addressed to J. Vargas-Villarreal;

Received 13 October 2017; Revised 7 February 2018; Accepted 25 June 2018; Published 11 July 2018

Academic Editor: Jose F. Silveira

Caption: FIGURE 1: Comparative 5-day growth of E. histolytica trophozoites in PEHPS, TYI-S-33, and CLUPS. Results are represented as mean [+ or -] SD of quintuplicated assays.

Caption: FIGURE 2: Phospholipase A1 (A1) andphospholipase A2 (A2) activity of P30 trophozoite fractions as a function of time. E. histolytica trophozoites were grown in PEHPS, TYI-S-33, or CLUPS; mean [+ or -] SD of quintuplicated assays.

Caption: FIGURE 3: Phospholipase A1 (A1) and phospholipase A2 (A2) activity of P30 trophozoite fractions accordingto protein amount. E. histolytica trophozoites were grown in PEHPS, TYI-S-33, or CLUPS; mean [+ or -] SD of quintuplicated assays.
Table 1: Composition of the culture media, PEHPS, TYI-S-33, and CLUPS.

Component                               Brand        PEHPS [9]

Liver and pancreas extract (mL)       In-house          250
Lung and pancreas extract (mL)        In-house         None
Liver infusion broth (g)              BD Difco         None
Casein peptone (g)                    BD Bioxon         10
Ascorbic acid (g)                   Sigma Aldrich       0.2
Cysteine (g)                        Sigma Aldrich       1.0
Glucose (g)                        Tecnica quimica       6
[K.sub.2]HP[O.sub.4] (g)                Baker            1
K[H.sub.2]P[O.sub.4] (g)              Monterrey         0.6
Sodium chloride (g)                     Baker          None
Ferric citrate (g)                  Sigma Aldrich      None
Deionized water                                      Up to 1L

Component                          TYI-S-33    CLUPS

Liver and pancreas extract (mL)      None       None
Lung and pancreas extract (mL)       None       250
Liver infusion broth (g)              10        None
Casein peptone (g)                    20         10
Ascorbic acid (g)                     1          1
Cysteine (g)                          1         1.26
Glucose (g)                           10         6
[K.sub.2]HP[O.sub.4] (g)              1          1
K[H.sub.2]P[O.sub.4] (g)             0.6        0.6
Sodium chloride (g)                  3.3        None
Ferric citrate (g)                   0.02       None
Deionized water                    Up to 1L   Up to 1L
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Gonzalez-Salazar, F.; Meester, I.; De La Garza, F.J. Guzman; De La Garza- Salinas, L.H.; Sampayo-Rey
Publication:Journal of Parasitology Research
Date:Jan 1, 2018
Previous Article:Malaria and Geohelminthiasis Coinfections in Expectant Women: Effect on Maternal Health and Birth Outcomes in a Malaria Endemic Region in Kenya.
Next Article:Identification of Fasciola Species Isolates from Nghe An Province, Vietnam, Based on ITS1 Sequence of Ribosomal DNA Using a Simple PCR-RFLP Method.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |